# Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed

> **NCT05592756** · — · COMPLETED · sponsor: **The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)** · enrollment: 2964 (actual)

## Conditions studied

- Measles

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05592756
- **Lead sponsor:** The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-06
- **Primary completion:** 2021-08-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 2964 (ACTUAL)
- **Last updated:** 2023-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05592756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05592756, "Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05592756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*